PLGA nanoparticles co-delivering BCL2 and MDR1 siRNA for overcoming resistance of paclitaxel and cisplatin in recurrent or advanced ovarian cancer

Authors
Chitra RisnayantiAhn Hyung Jun
Citation
Pharmaceutics and Drug Delivery Systems
Keywords
siRNA; Chemoresistance; PLGA nanoparticles; ovarian cancer; chemotherapy; combination therapy
URI
https://pubs.kist.re.kr/handle/201004/87068
Appears in Collections:
KIST Conference Paper > Others
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE